ICPMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma from Agilent Technologies | LabRulez ICPMS

    Analysis of pharmaceuticals and drug related impurities using Agilent instrumentation

    Guides
    | 2010 | Agilent Technologies
    GC, GC/MSD, HeadSpace, GC/SQ, HPLC, Ion chromatography, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/SQ, ICP/MS
    Instrumentation
    GC, GC/MSD, HeadSpace, GC/SQ, HPLC, Ion chromatography, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/SQ, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Pharmaceutical Analysis using FTIR: Compliance with European, US, Indian, and Japanese Pharmacopoeia

    Technical notes
    | 2022 | Agilent Technologies
    FTIR Spectroscopy
    Instrumentation
    FTIR Spectroscopy
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Spectroscopy Solutions for Pharmaceuticals

    Technical notes
    | 2016 | Agilent Technologies
    UV–VIS spectrophotometry
    Instrumentation
    UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Data Integrity Options for GMP Facilities For the Agilent Cary 3500 UV-Vis Spectrophotometer

    Others
    | 2022 | Agilent Technologies
    Software, UV–VIS spectrophotometry
    Instrumentation
    Software, UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Workflow Breakthroughs That are Improving Data Quality and Efficiency

    Others
    | 2020 | Agilent Technologies
    UV–VIS spectrophotometry
    Instrumentation
    UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Pharmaceutical Analysis Using UV-Vis: Compliance with USP Chapter <857>, and European Pharmacopoeia (Ph. Eur. Chapter 2.2.25)

    Applications
    | 2020 | Agilent Technologies
    UV–VIS spectrophotometry
    Instrumentation
    UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Rapid Identification of Raw Materials Inside Packaging

    Applications
    | 2021 | Agilent Technologies
    RAMAN Spectroscopy
    Instrumentation
    RAMAN Spectroscopy
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Pharmaceutical Analysis using UV-Vis: Compliance with Supplement I to the Japanese Pharmacopoeia 18th Ed., Section 2.24

    Technical notes
    | 2021 | Agilent Technologies
    Software, UV–VIS spectrophotometry
    Instrumentation
    Software, UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Alcohol Levels Determination in Hand Sanitizers by FTIR

    Manuals
    | 2020 | Agilent Technologies
    FTIR Spectroscopy
    Instrumentation
    FTIR Spectroscopy
    Manufacturer
    Agilent Technologies
    Industries
    Energy & Chemicals , Pharma & Biopharma

    ICP Expert Software Installation Instructions for 21 CFR Part 11 Environments

    Manuals
    | 2018 | Agilent Technologies
    Software, ICP/OES
    Instrumentation
    Software, ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma
     

    Related content


    An innovative approach to planar chiral substances

    Mo, 27.5.2024
    Katedra organické chemie Přírodovědecké fakulty Univerzity Karlovy

    Gerrit Angst awarded the Lumina quaeruntur premium. He will start a new research team

    Th, 23.5.2024
    Akademie věd České republiky

    New approach enhances muscle recovery in aged mice

    We, 22.5.2024
    University of Illinois Urbana-Champaign
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike